Systemic lupus erythematosus subgroups, with features of antiphospholipid or Sjogren's syndrome, differ in molecular signatures and treatment perspectives

导出原文传递

翻译打印收藏纠错

作者： Idborg, H. ^[1] ; Zandian, A. ^[2] ; Sandberg, A. ^[3] ; Truedsson, L. ^[4] ; Nilsson, B. ^[5] ; Elvin, K. ^[6] ; Mo, J. ^[7] ; Gustafsson, J. ; Gunnarsson, I. ; Lehtio, J. ; Nilsson, P. ; Svenungsson, E. ; Jakobsson, P.

作者单位： Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden ^[1] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden ^[2] AstraZeneca, R&D, Molndal, Sweden ^[3] Uppsala Univ, Dept Immunol, Uppsala, Sweden ^[4] Karolinska Inst, Dept Med, Solna, Sweden ^[5] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden ^[6] Lund Univ, Dept Lab Med, Lund, Sweden ^[7]

发布时间 2018-11-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Scandinavian journal of rheumatology

2018年47卷Suppl.129期

2-2页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Systemic lupus erythematosus subgroups, with features of antiphospholipid or Sjogren's syndrome, differ in molecular signatures and treatment perspectives

Scandinavian journal of rheumatology

相似文献

Scandinavian journal of rheumatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Systemic lupus erythematosus subgroups, with features of antiphospholipid or Sjogren's syndrome, differ in molecular signatures and treatment perspectives

Scandinavian journal of rheumatology

相似文献

Scandinavian journal of rheumatology

相关期刊

检索历史清除